Co-Authors
This is a "connection" page, showing publications co-authored by GARY E GALLICK and DOUGLAS D BOYD.
Connection Strength
0.648
-
Combination of an SRC kinase inhibitor with a novel pharmacological antagonist of the urokinase receptor diminishes in vitro colon cancer invasiveness. Clin Cancer Res. 2004 Feb 15; 10(4):1545-55.
Score: 0.247
-
A urokinase-derived peptide (A6) increases survival of mice bearing orthotopically grown prostate cancer and reduces lymph node metastasis. Am J Pathol. 2003 Feb; 162(2):619-26.
Score: 0.230
-
Plasticity in urokinase-type plasminogen activator receptor (uPAR) display in colon cancer yields metastable subpopulations oscillating in cell surface uPAR density--implications in tumor progression. Cancer Res. 2006 Aug 15; 66(16):7957-67.
Score: 0.073
-
Activation of Src kinase in primary colorectal carcinoma: an indicator of poor clinical prognosis. Cancer. 2002 Jan 15; 94(2):344-51.
Score: 0.053
-
Transcriptional induction of the urokinase receptor gene by a constitutively active Src. Requirement of an upstream motif (-152/-135) bound with Sp1. J Biol Chem. 1999 Jun 25; 274(26):18428-37.
Score: 0.045